ConductScience.org, home

Paper39455652

In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants.

Sharma S and 2 others. Sci Rep, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants. Papers, record 39455652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39455652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants.
PubMed
Journal
Sci Rep
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.38, provisional
iCite
Revised in PubMed
2024-10-28
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sharma SShivangi
2Roy DDiya
3Cherian SSarah

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SARS-CoV-2Major topic
COVID-19Major topic
Epitopes, T-LymphocyteMajor topic
Computer SimulationMajor topic
MutationMajor topic
Humans
Cross Reactions
CD8-Positive T-Lymphocytes
CD4-Positive T-Lymphocytes
COVID-19 Vaccines
T-Lymphocytes

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
09/0698(13659)/2022-EMR-ICouncil of Scientific and Industrial Research, IndiaPubMed

Source PubMed

Download CSV of grants

References75

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132680954SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.Sci Immunol2020https://conductscience.org/library/papers/32680954PubMed
235105982The T cell immune response against SARS-CoV-2.Nat Immunol2022https://conductscience.org/library/papers/35105982PubMed
328382917GISAID: Global initiative on sharing all influenza data - from vision to reality.Euro Surveill2017https://conductscience.org/library/papers/28382917PubMed
433547334An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.Sci Rep2021https://conductscience.org/library/papers/33547334PubMed
524058508In silico approach for predicting toxicity of peptides and proteins.PLoS One2013https://conductscience.org/library/papers/24058508PubMed
610027275Protein identification and analysis tools in the ExPASy server.Methods Mol Biol1999https://conductscience.org/library/papers/10027275PubMed
724304645Designing of interferon-gamma inducing MHC class-II binders.Biol Direct2013https://conductscience.org/library/papers/24304645PubMed
834171266SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.Cell Host Microbe2021https://conductscience.org/library/papers/34171266PubMed
933225084Designing spike protein (S-Protein) based multi-epitope peptide vaccine against SARS COVID-19 by immunoinformatics.Heliyon2020https://conductscience.org/library/papers/33225084PubMed
1032015507A pneumonia outbreak associated with a new coronavirus of probable bat origin.Nature2020https://conductscience.org/library/papers/32015507PubMed
1134824381Heavily mutated Omicron variant puts scientists on alert.Nature2021https://conductscience.org/library/papers/34824381PubMed
1233112236Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.Elife2020https://conductscience.org/library/papers/33112236PubMed
1332903476The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19.Front Immunol2020https://conductscience.org/library/papers/32903476PubMed
1434314723The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic.Curr Biol2021https://conductscience.org/library/papers/34314723PubMed
1535987196SARS-CoV-2 vaccine-induced antibody and T cell response in SARS-CoV-1 survivors.Cell Rep2022https://conductscience.org/library/papers/35987196PubMed
1635772405Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.Cell2022https://conductscience.org/library/papers/35772405PubMed
1733664060SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses.Sci Immunol2021https://conductscience.org/library/papers/33664060PubMed
1835016195Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.Nature2022https://conductscience.org/library/papers/35016195PubMed
1934634791Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity.Nature2021https://conductscience.org/library/papers/34634791PubMed
2032308001Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data.J Proteome Res2020https://conductscience.org/library/papers/32308001PubMed

See all 75 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42477893Antigenic Variation and Immune Recognition Inference From the COVID-19 Pandemic: An In Silico Comparative Analysis of Spike T Cell Epitopes From the SARS-CoV-2 Variants of Concern.Influenza Other Respir Viruses2026https://conductscience.org/library/papers/42477893PubMed
41368482T-Cell Interferon Gamma Responses to SARS-CoV-2 Following Infection with/Without Vaccination in a Tanzanian Population.Infect Drug Resist2025https://conductscience.org/library/papers/41368482PubMed
40489562Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patients.PLoS Comput Biol2025https://conductscience.org/library/papers/40489562PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-S267015PubTator's text mininghttps://conductscience.org/library/genes/267015NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39455652

GET https://conductscience.org/api/papers/v1/39455652/references?page=2